43 reports

A cerebral aneurysm occurs due to hypertension, smoking, injury or trauma to blood vessels, and genetic predisposition.

  • Cardiovascular Devices
  • Abbott Laboratories, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • Terumo Corporation

GENETIC MAKEUP ALSO PLAYS A MAJOR PART IN THE DEVELOPMENT OF AORTIC ANEURYSMS.

  • Cardiovascular Devices
  • World
  • Market Size
  • Endologix, Inc.
  • Medtronic, Inc.

At least ##% of all CHDs are associated with genetic conditions.

  • Cardiovascular Devices
  • World
  • Market Size
  • Terumo Corporation
  • Toshiba Corporation
  • MARKET SIZE AND FORECAST

Genetic and co-morbid influences also play major roles in the increasing incidences of PVDs.

  • Cardiovascular Devices
  • Interventional Cardiology Device
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.

Modifiable risk factors HYPERCHOLESTEROLEMIA HYPERTENSION DIABETES OBESITY SEDENTARY LIFESTYLE SMOKING DEPRESSION AND STRESS Non-modifiable risk factors AGE GENDER GENETIC AND HEREDITARY FACTORS THE PATHOPHYSIOLOGY INVOLVED IN CAD CAN BE ILLUSTRATED AS FOLLOWS: Pathophysiology Pathophysiolo

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Opsens Inc.

Moreover, a rise in the incidence of genetic comorbidities is one of the factors responsible for the increase in the incidence of diseases that require thoracic surgery.

  • Cardiovascular Devices
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sorin S.p.A.

SEEING THE IMPORTANCE OF RECOGNIZING INNOVATION IN ART TECHNOLOGIES, THE GLOBAL FERTILITY ALLIANCE WAS FOUNDED BY MERCK TOGETHER WITH TWO STRATEGIC PARTNERS: ILLUMINA, A LEADER IN DEVELOPING AND COMMERCIALIZING SYSTEMS FOR ANALYSIS OF GENETIC VARIATION AND FUNCTION, AND GENEA, A DEVELOPER O

  • Cardiovascular Devices
  • Australia
  • Oceania
  • Forecast
  • Olympus Corporation
  • 11. Market Growth Drivers
  • 06.2 Market Size and Forecast

Genetic and co-morbid factors are major contributors too.

  • Cardiovascular Devices
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.

The increase in the prevalence of diabetes is common in all age groups of people; genetic factors and changes in lifestyle are some of the reasons for the increase.

  • Cardiovascular Devices
  • Forecast
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • 6.1 Growth Drivers

Increasing consumption of fast food, diet colas, and genetic disorder cases, have aggravated the scale of obese people globally.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Cordis Corporation
  • Johnson & Johnson
  • 4.4.4 STENT GRAFTS

PERIPHERAL ANEURYSMS ARE USUALLY GENETIC.

  • Cardiovascular Devices
  • World
  • Market Size
  • Boston Scientific Corporation
  • Medtronic, Inc.

CSL Behring engineered rIX-FP to extend the half-life of recombinant factor IX through genetic fusion with recombinant albumin.

  • Cardiovascular Devices
  • Europe
  • Germany
  • Forecast
  • Market Size
  • Market landscape

ALONG WITH INCREASED SMOKING, HYPERTENSION, HIGH CHOLESTEROL LEVELS, AND DIABETES, GENETIC COMPLICATIONS AND CO-MORBIDITIES ARE MAJOR RISK FACTORS FOR THE DISEASE.

  • Cardiology
  • Cardiovascular Devices
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Spectranetics Corp.

Women belonging to a specific ethnic group are also genetically prone to preterm births.

  • Cardiovascular Devices
  • World
  • Market Size
  • Medtronic, Inc.
  • Roche Group
  • Global Percutaneous Coronary Interventions Procedures Forecast ($m), 2013-2022

India is the most significantly impacted by the disease, where genetic factors, in combination with poor diet, have contributed to the rising rate of the disease.

  • Cardiovascular Devices
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik AG
  • Boston Scientific Corporation
  • 3.3.2 RESTRAINTS AND THREATS
  • 5.2.2 PERIPHERAL STENTS

Increasing incidences of intracranial disorders due to accidents and genetic disorders, and growing aging populations are driving the intracranial stent market whereas; the limitations of intracranial stenting such as applicable only for selective patient groups and risk of stroke are hampe

  • Cardiovascular Devices
  • World
  • Market Size
  • Abbott
  • Biosensors International Group, Ltd.

India is most significantly impacted by the disease, where genetic factors, in combination with poor diet, have contributed to the rising rate of diabetes.

  • Cardiovascular Devices
  • World
  • Forecast
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • 4.2.2 Prostatic Stents Market, US$ Mn (2013 - 2019)

Major drivers include increasing adoption of prostatic stents worldwide, genetic susceptibility of certain ethnicity for prostate cancer and BPH (particularly African decent).

  • Cardiovascular Devices
  • World
  • Forecast
  • Boston Scientific Corporation
  • Taewoong Medical

Genetic Diagnosis (PGD) Market 2014-2018 Global Sexually Transmitted Disease (STD) Testing Market 2014-2018 DISCLAIMER ABOUT TECHNAVIO INSIGHTS This report has been prepared from sources and data that we believe to be reliable, but we make no representation as to its accuracy or completenes

  • Cardiac Management
  • Cardiovascular Devices
  • Europe
  • Boston Scientific Corporation
  • Jude Medical, Inc.

Genetic Diagnosis (PGD) Market 2014-2018 Global Sexually Transmitted Disease (STD) Testing Market 2014-2018 DISCLAIMER ABOUT TECHNAVIO INSIGHTS This report has been prepared from sources and data that we believe to be reliable, but we make no representation as to its accuracy or completenes

  • Cardiovascular Devices
  • China
  • Cook Medical, Inc.
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030

WITH AGE, GENETIC AND LIFESTYLE FACTORS LEAD TO A BUILDUP OF PLAQUE IN THE ARTERIES. ##. ##. ##. ## ACCORDING TO AN ARTICLE PUBLISHED IN THE LANCET JOURNAL IN OCTOBER 2016, THE GLOBAL PREVALENCE OF PERIPHERAL VASCULAR DISEASES WAS ##. ## MILLION IN 2005, WHICH ROSE TO ##. ## MILLION IN 2015.

  • Cardiovascular Devices
  • Asia
  • Europe
  • World
  • Medtronic, Inc.

-Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy - On July ##, 2015, Transgenomic announced the launch of a new genetic test for the definitive diagnosis of the devastating genetic disorders known as leukodystrophies, which are current

  • Cardiovascular Devices
  • Medical Device
  • North America
  • United States
  • AtriCure, Inc.

In 2012, it was also estimated that more than ##% of the population in the U. S. was prone to venous thrombosis due to various genetic risk factors.

  • Cardiovascular Devices
  • Diagnostic Imaging
  • Radiology
  • Urology
  • Medtronic, Inc.
  • NF-KB DECOY OLIGO COATED PTA BALLOON CATHETER - PRODUCT STATUS
  • ANGES MG INC PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

The company specializes in research and development (R& D) and practical application of genetic medicine.

  • Cardiology
  • Cardiovascular Devices
  • Clinical Trial
  • Drug Discovery And Development
  • GlobalData's company

HE IS BOTH A LICENSED AND CERTIFIED GENETIC COUNSELOR.

  • Body Contouring Device
  • Cardiovascular Devices
  • North America
  • United States
  • Forecast
  • ANGES MG TERMINATES PUBLIC OFFERING OF SHARES FOR UP TO USD26 MILLION
  • ANGES MG TERMINATES PRIVATE PLACEMENT OF SHARES FOR UP TO USD3.3 MILLION

Antoine Yver, Head of Oncology, Global Medicines Development, AstraZeneca, said: " We are committed to developing novel medicines that address the significant unmet need in lung cancer by focusing on the genetic drivers underlying the disease.

  • Cardiovascular Devices
  • Asia
  • Japan
  • Forecast
  • Market Size
  • ANGES MG, INC. PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • COLLATEGENE DRUG-ELUTING BALLOON CATHETER - PRODUCT STATUS

The company specializes in R& D and practical application of genetic medicine.

  • Cardiovascular Devices
  • Clinical Trial
  • Peripheral Vascular Device
  • United States
  • GlobalData's company
  • CYTOGRAFT TISSUE ENGINEERING INC (INACTIVE) PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • LIFEJACKET AAA STENT GRAFT - PRODUCT DESCRIPTION

genetic engineering company that offers therapies.

  • Cardiovascular Devices
  • Clinical Trial
  • Healthcare IT
  • Interventional Cardiology Device
  • GlobalData's company

-TRANSGENOMIC LAUNCHES MOST COMPREHENSIVE GENETIC TEST FOR DIAGNOSIS OF LEUKODYSTROPHY - ON JULY ##, 2015, TRANSGENOMIC ANNOUNCED THE LAUNCH OF A NEW GENETIC TEST FOR THE DEFINITIVE DIAGNOSIS OF THE DEVASTATING GENETIC DISORDERS KNOWN AS LEUKODYSTROPHIES, WHICH ARE CURRENT

  • Cardiovascular Devices
  • North America
  • United States
  • Forecast
  • Market Size